期刊档案 · MEDICINE, RESEARCH & EXPERIMENTAL
Advances in Clinical and Experimental Medicine
ISSN 1899-5276 · eISSN 2451-2680 · Wroclaw Medical University · POLAND · 创刊 1998
Advances in Clinical and Experimental Medicine 中科院 医学 4区（2025 年升级版），影响因子 2.46，完全开放获取，收取 APC，金额未公布，近 24 个月 111 篇文章投稿到接收中位 121 天，录用比例容易（社区反馈），2025 年发文 123 篇，SCIE、Scopus 收录。
研究范围
研究范围与定位
Advances in Clinical and Experimental Medicine 由 Wroclaw Medical University 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 MicroRNA in disease regulation、Oral microbiology and periodontitis research、Cancer-related molecular mechanisms research 等主题的论文，这 3 个主题约占 17.2%。（根据 OpenAlex 主题统计与中科院分区数据生成）
Advances in Clinical and Experimental Medicine (Adv Clin Exp Med) is an international, peer-reviewed journal that highlights the full translational pathway of biomedical research – from laboratory discoveries (“bench”), through clinical application (“bedside”), to real-world practice and policy (“implementation”). The journal welcomes original research articles, reviews/meta-analyses, clinical recommendations/guidelines, research-in-progress reports, research letters, and study protocols authored by recognized experts in clinical and experimental medicine. The journal does not publish case studies, case series, and bibliometric studies. By embracing this translational continuum, Adv Clin Exp Med serves as a platform for studies that not only advance scientific knowledge but also demonstrate clear potential to improve patient outcomes and healthcare systems. We particularly value contributions that bridge gaps between experimental insights, clinical trials, and the implementation of evidence-based practices in diverse medical settings, especially those developed by international, multi-center research teams.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：MEDICINE, RESEARCH & EXPERIMENTAL
主编 Donata Kurpas出版商官网
编委会国家分布：未见中国大陆编委；主要国家 波兰 11（共 11 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology7.4%
- Oral microbiology and periodontitis researchDentistry5.2%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology4.6%
- Dental materials and restorationsDentistry4.5%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine4.5%
- Dialysis and Renal Disease ManagementMedicine4.3%
- Cardiovascular Function and Risk FactorsMedicine4.3%
- Circular RNAs in diseasesBiochemistry, Genetics and Molecular Biology4.3%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 医学：研究与实验MEDICINE, RESEARCH & EXPERIMENTAL | 4 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 医学：研究与实验MEDICINE, RESEARCH & EXPERIMENTAL | 4 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 医学：研究与实验MEDICINE, RESEARCH & EXPERIMENTAL | 4 区 |
Top 期刊：否综述期刊：否
数据库收录
SCIEScopusDOAJLetPub
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
Web of ScienceMEDLINEPubMed出版商官网
其他：Journal Impact Factor (JIF 2025) – 2.5、Journal Citation Indicator (JCI 2025) – 0.40、Index Copernicus Value (ICV 2024) – 161.00、MNiSW – 70 pts、Ulrich’s International Periodicals Directory、Index Copernicus、Journal Citation Reports/Science Edition
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 2.46LetPub ·
- 影响因子（出版商公布） 2025
- 2.5出版商官网 ·
- 五年影响因子（出版商公布） 2025
- 2.3出版商官网 ·
- CiteScore 2026-06
- 4.2LetPub ·
- CiteScore（出版商公布） 2025
- 4.2出版商官网 ·
- SJR 2026-06
- 0.6LetPub ·
- SJR（出版商公布）
- 0.6出版商官网 ·
- SNIP 2026-06
- 0.66LetPub ·
- h-index
- 21LetPub ·
- h-index
- 63OpenAlex ·
- i10-index
- 899OpenAlex ·
- 两年平均被引
- 2.05OpenAlex ·
- 自引率
- 8%LetPub ·
- Gold OA 文章占比
- 99.28%LetPub ·
发文规模
- 年文章数
- 92LetPub ·
- 年发文量（出版商公布）
- 70出版商官网 ·
逐年发文量 OpenAlex 统计 · 累计 2,572 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 156 | 156 | 36 |
| 2025 | 123 | 123 | 178 |
| 2024 | 167 | 167 | 701 |
| 2023 | 188 | 188 | 1,254 |
| 2022 | 181 | 181 | 1,899 |
| 2021 | 169 | 169 | 2,136 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 PubMed 登记的稿件日期 · 至
121 天投稿到接收中位数 · P25–P75 79 天 – 175 天
- 接收到上线
- 中位数 99 天（28 篇）
- 投稿到上线
- 中位数 201 天
- 样本
- 111 篇有投稿与接收日期的文章（窗口内共 397 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度（社区反馈）
- 较慢,6-12周LetPub ·
- 平均录用比例（社区反馈）
- 容易LetPub ·
- 投稿到发表（期刊自报）
- 约 54 周DOAJ ·
- 评审方式
- 双盲同行评审DOAJ
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
完全开放获取DOAJ
所有文章开放获取，通常向作者收取文章处理费（APC）。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | EUR 1,600 / PLN 6,900 | 有 | CC BY | |
| OpenAlex | EUR 700 | — | — | |
| LetPub | EUR 1,600 / PLN 6,900 | 有 | — | |
| 出版商官网 | EUR 1,600 / EUR 990 / EUR 700 / EUR 350 | — | — |
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
接收的文章类型7 种，含篇幅限制
- commentaryManuscripts may be considered for publication in the following sections: Original papers – including experimental research Reviews Meta-Analyses Research-in-Pro…正文 ≤ 1,500 词
- editorialManuscripts may be considered for publication in the following sections: Original papers – including experimental research Reviews Meta-Analyses Research-in-Pro…未说明篇幅
- letterManuscripts may be considered for publication in the following sections: Original papers – including experimental research Reviews Meta-Analyses Research-in-Pro…正文 ≤ 7,000 词
- meta-analysisManuscripts may be considered for publication in the following sections: Original papers – including experimental research Reviews Meta-Analyses Research-in-Pro…未说明篇幅
- original paperManuscripts may be considered for publication in the following sections: Original papers – including experimental research Reviews Meta-Analyses Research-in-Pro…正文 ≤ 1,500 词
- protocolManuscripts may be considered for publication in the following sections: Original papers – including experimental research Reviews Meta-Analyses Research-in-Pro…未说明篇幅
- reviewManuscripts may be considered for publication in the following sections: Original papers – including experimental research Reviews Meta-Analyses Research-in-Pro…未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、出版伦理、许可与版权、同行评审、预印本
- AI 使用 Authorship and AI tools – COPE position statement
The use of artificial intelligence (AI) tools, such as ChatGPT or Large Language Models, in research publications is expanding rapidly. COPE joins organisations, such as WAME and the JAMA Network, among others, to state that AI tools cannot be listed as an author of a paper. AI tools cannot meet the requirements for authorship, as they cannot take responsibility for the submitted work. As non-lega…
原文 ↗出版商官网 ·- 作者资格 Authorship
Manuscript withdrawal policy: requires clear reason and consent of all authors. 模型摘要
No information allowing for authors' identification, in particular authors' names, should appear anywhere in the main body of the paper. All Authors who have made significant contributions should be listed as co-authors, and their authorship should be disclosed in the Editorial System under the following list: A – research concept and design; B – collection and/or assembly of data; C – data analys…
原文 ↗出版商官网 ·- 利益冲突 Conflict of interest
Any conflict of interest should be reported while submitting the manuscript in a dedicated section of the submission procedure in our Editorial System, not in the Acknowledgements section or in the paper itself. All authors must provide disclosures before submission for inclusion in the “Conflict of Interest” statement. A conflict of interest exists when one’s professional judgment about the execu…
原文 ↗出版商官网 ·- 数据可用性 Policy concerning data sharing
Adv Clin Exp Med requires the Authors of all original papers to make all data necessary to replicate their study's results publicly available without restriction when the paper is submitted to the journal (relevant information must be registered in the Editorial System at the time of submission). All the data and related metadata underlying the reported findings should be deposited in appropriate …
原文 ↗出版商官网 ·- 出版伦理 If ethical approval applies, its number is included in the text.
Abbreviations explained in the text, not on a separate list.
原文 ↗出版商官网 ·- 许可与版权 Our copyright declaration
The Author/Author(s) declare that: a) they are copyright holders of the scientific work/publication; b) they are entitled to dispose of copyright for the concluded license/publishing agreement with the Wroclaw Medical University; c) they created the work/publication on their own; d) the work/publication does not violate the rights of third parties. If a third party files a claim against Wroclaw Me…
原文 ↗出版商官网 ·- 同行评审
The journal does not publish case studies, case series, and bibliometric studies. 模型摘要
The journal does not publish case studies, case series, and bibliometric studies.
原文 ↗出版商官网 ·- 预印本 Policy regarding preprints
Adv Clin Exp Med endorses and encourages the posting of manuscript preprints on non-profit preprint servers such as BioRxiv, MedRxiv, ResearchSquare, or Authorea, as well as on authors’ or institutional websites. Posting preprints is not considered a prior publication, and the manuscript can enter peer review at Adv Clin Exp Med following the regular procedure. Preprints are defined as an author’s…
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Wroclaw Medical University
- 出版国家或地区
- POLAND
- 出版语言
- English
- 创刊年份
- 1998
- ISSN
- 1899-5276
- 电子版 ISSN
- 2451-2680
- 官方链接
- 期刊主页 ↗DOAJ
- 投稿系统 ↗出版商官网
- 作者指南 ↗LetPub
- Aims & Scope ↗LetPub
- 专刊 / 特刊征稿 ↗出版商官网
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗LetPub
- 编委会 ↗LetPub
- 查重政策 ↗DOAJ
常见问题
关于 Advances in Clinical and Experimental Medicine 的常见问题
Advances in Clinical and Experimental Medicine 是中科院几区期刊？
2025 年升级版分区表中，Advances in Clinical and Experimental Medicine 为医学 4区，小类 医学：研究与实验 4 区。2026 年新锐版分区表中为医学 4区。不同版本与大小类分区不能混用。
Advances in Clinical and Experimental Medicine 的影响因子是多少？
LetPub 汇总的最新公布影响因子为 2.46，CiteScore 为 4.2，h-index 为 63。
Advances in Clinical and Experimental Medicine 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）111 篇已发表文章登记的日期，投稿到接收的中位数为 121 天（四分位 79–175 天）；投稿社区反馈的平均审稿速度为6–12 周，平均录用比例反馈为“容易”。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Advances in Clinical and Experimental Medicine 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 11 位编委中，没有中国大陆学者；人数最多的国家是 波兰（11 位）。统计按编委会页面列出的机构国家计，仅供参考。
Advances in Clinical and Experimental Medicine 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Advances in Clinical and Experimental Medicine 被 SCIE、Scopus、DOAJ 收录。期刊官网自述还被 Web of Science、MEDLINE、PubMed 收录，该清单未与各数据库逐一核对。
Advances in Clinical and Experimental Medicine 是开放获取期刊吗？版面费多少？
Advances in Clinical and Experimental Medicine 为完全开放获取。收取 APC，金额未公布。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网、DOAJ；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。